RIG
ABBV icon

Renaissance Investment Group’s AbbVie ABBV Stock Holding History

Renaissance Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Hold
9,842
– – 0.49% 38
2026
Q1 		$2.14M Sell
9,842
-198
-2% -$43.9K 0.46% 39
2025
Q4 		$2.29M Sell
10,040
-523
-5% -$119K 0.46% 38
2025
Q3 		$2.45M Sell
10,563
-10
-0.1% -$2.04K 0.5% 38
2025
Q2 		$1.96M Hold
10,573
– – 0.43% 39
2025
Q1 		$2.22M Sell
10,573
-1,045
-9% -$203K 0.54% 37
2024
Q4 		$2.06M Sell
11,618
-555
-5% -$102K 0.44% 42
2024
Q3 		$2.4M Sell
12,173
-40
-0.3% -$7.46K 0.5% 40
2024
Q2 		$2.05M Sell
12,213
-525
-4% -$87K 0.45% 41
2024
Q1 		$2.32M Sell
12,738
-500
-4% -$86.2K 0.53% 41
2023
Q4 		$2.05M Buy
13,238
+50
+0.4% +$7.29K 0.51% 41
2023
Q3 		$1.97M Sell
13,188
-1,800
-12% -$264K 0.55% 41
2023
Q2 		$2.02M Sell
14,988
-174
-1% -$25.5K 0.53% 42
2023
Q1 		$2.42M Sell
15,162
-222
-1% -$33.9K 0.68% 41
2022
Q4 		$2.49M Sell
15,384
-709
-4% -$109K 0.74% 41
2022
Q3 		$2.43M Buy
16,093
+12,172
+310% +$1.75M 0.76% 42
2022
Q2 		$601K Buy
3,921
+261
+7% +$39.9K 0.2% 55
2022
Q1 		$541K Sell
3,660
-25
-0.7% -$3.63K 0.16% 59
2021
Q4 		$499K Sell
3,685
-1,012
-22% -$120K 0.12% 62
2021
Q3 		$507K Sell
4,697
-150
-3% -$17.1K 0.13% 61
2021
Q2 		$546K Sell
4,847
-175
-3% -$19.7K 0.14% 60
2021
Q1 		$543K Hold
5,022
– – 0.15% 60
2020
Q4 		$538K Sell
5,022
-250
-5% -$24K 0.16% 59
2020
Q3 		$462K Hold
5,272
– – 0.15% 55
2020
Q2 		$518K Sell
5,272
-50
-0.9% -$4.4K 0.19% 52
2020
Q1 		$405K Buy
5,322
+600
+13% +$51.1K 0.19% 52
2019
Q4 		$418K Buy
4,722
+125
+3% +$10.4K 0.15% 61
2019
Q3 		$348K Buy
4,597
+272
+6% +$18.6K 0.13% 64
2019
Q2 		$314K Sell
4,325
-150
-3% -$11.8K 0.12% 71
2019
Q1 		$361K Sell
4,475
-100
-2% -$8.18K 0.15% 63
2018
Q4 		$422K Sell
4,575
-1,916
-30% -$168K 0.2% 52
2018
Q3 		$614K Sell
6,491
-28
-0.4% -$2.65K 0.24% 52
2018
Q2 		$604K Sell
6,519
-100
-2% -$9.77K 0.24% 50
2018
Q1 		$627K Sell
6,619
-40
-0.6% -$4.39K 0.25% 52
2017
Q4 		$644K Buy
6,659
+54
+0.8% +$5.09K 0.26% 52
2017
Q3 		$587K Sell
6,605
-25
-0.4% -$1.9K 0.25% 54
2017
Q2 		$480K Hold
6,630
– – 0.21% 55
2017
Q1 		$432K Sell
6,630
-1,870
-22% -$118K 0.19% 62
2016
Q4 		$532K Sell
8,500
-200
-2% -$12.2K 0.25% 57
2016
Q3 		$549K Buy
8,700
+150
+2% +$9.71K 0.26% 54
2016
Q2 		$529K Buy
8,550
+640
+8% +$39K 0.26% 52
2016
Q1 		$452K Sell
7,910
-598
-7% -$33.3K 0.23% 57
2015
Q4 		$504K Buy
8,508
+1,368
+19% +$78.8K 0.25% 56
2015
Q3 		$389K Hold
7,140
– – 0.2% 53
2015
Q2 		$479K Sell
7,140
-160
-2% -$10.4K 0.22% 51
2015
Q1 		$427K Sell
7,300
-160
-2% -$9.67K 0.2% 53
2014
Q4 		$488K Hold
7,460
– – 0.23% 53
2014
Q3 		$431K Hold
7,460
– – 0.21% 56
2014
Q2 		$421K Hold
7,460
– – 0.2% 56
2014
Q1 		$383K Hold
7,460
– – 0.19% 58
2013
Q4 		$394K Sell
7,460
-800
-10% -$39.3K 0.2% 59
2013
Q3 		$369K Sell
8,260
-390
-5% -$17.3K 0.2% 58
2013
Q2 		$357K Buy
+8,650
New +$378K 0.2% 61

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Renaissance Investment Group's ABBV Position: Q2 2026 in Review

Renaissance Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 9,842 shares worth $2.48M. The position accounts for 0.49% of the portfolio, ranked #38.

Renaissance Investment Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.49M in Q4 2022. 1,043 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Renaissance Investment Group held 9,842 shares of AbbVie worth $2.48M as of Q2 2026.
  • Renaissance Investment Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.49% of Renaissance Investment Group's portfolio in Q2 2026, its #38 holding.
  • Renaissance Investment Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Renaissance Investment Group's AbbVie position peaked at $2.49M in Q4 2022.
  • 1,043 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Renaissance Investment Group's 13F filing for Q2 2026, filed 8 Jul 2026.